This relationship underscores the potential for targeting leptin pathways as a therapeutic strategy to mitigate cognitive decline and address the metabolic aspects of neurodegenerative diseases [85,116,156,157,158]. The gene discussed is LEP; the disease is neurodegenerative disease.